John De Vos
7.9K posts

John De Vos
@_jdevos_
#stemcells researcher | Director of Cell Processing Facility @umontpellier @CHU_Montpellier | #iPScells #lung | @stemgenomics
Montpellier, France Katılım Temmuz 2009
1K Takip Edilen1.4K Takipçiler
John De Vos retweetledi
John De Vos retweetledi

One of my favorite data journalists is @jburnmurdoch and he is cooking once again with this piece: “In country after country the birth rate plunged after the introduction of smartphones, no matter what the previous trend was…the modern digital media environment has had profound effects on society that have led to a decline in romantic coupling”. Read here: ft.com/content/fba35e…

English

Anti-CD33 #CARTCells vs normal hematopoiesis? Protect healthy myeloid cells first: delete CD33 before CAR-T infusion!
CRISPR−Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial
nature.com/articles/s4159…
English
John De Vos retweetledi
John De Vos retweetledi
John De Vos retweetledi

John De Vos retweetledi

Étudier à Montpellier, ça vous parle ? 🌞📚
Participez à l’enquête annuelle de @letudiant pour élire les villes où il fait bon étudier et faites entendre la voix des étudiants montpelliérains 👇
fr.surveymonkey.com/r/villesetudia…

Français
John De Vos retweetledi

This seems to be the strongest Niño that the NMME has predicted in its May forecasts. Certainly dwarfs those forecast in 2023 and even 2015. Obviously, we'll see how it actually verifies, but it's another indicator we could be seeing a very high-end event coming.



Ben Noll@BenNollWeather
New NMME modeling shows the *strongest El Niño on record* unfolding from October 2026 through at least January 2027. Sea temperatures in the central equatorial Pacific are forecast to soar 3.1˚C above average, reaching a peak in November.
English
John De Vos retweetledi

IA outperforms clinicians in clinical interview of patients!
Samuel Schmidgall@SRSchmidgall
Doctors have known for decades: the clinical interview is the most important diagnostic tool Turns out, the same is true for AI In work led by @breda_joe, @jesunshine, and @danmcduff, we randomized 13,917 Fitbit users across 5 AI strategies for symptom assessment 🧵
English

Century Therapeutics presents CNTY-813, its #iPSCells-derived islet replacement therapy for T1D. The Allo-Evasion™ 5.0, off-the-shelf beta islet platform aims to reduce or eliminate the need for chronic immunosuppression, with IND planned for Q4 2026.
investing.com/news/company-n…

English

Encouraging phase I data for off-the-shelf #iPSCells-derived #CARTCell product candidate for Systemic Lupus Erythematosus by Fate Therapeutics.
biospace.com/press-releases…
English
John De Vos retweetledi
John De Vos retweetledi
John De Vos retweetledi

The worst cancers with respect to lethality get the least federal funding support
jamanetwork.com/journals/jaman…

English

Sustained positive clinical results for autologous anti-CD19 #CARTCells in patients with moderate-to-severe generalized myasthenia gravis (Phase II trial).
ir.kyvernatx.com/news-releases/…
English

In vivo #CARTCells race for autoimmune grows as two RNA startups enter the clinic.
endpoints.news/in-vivo-car-t-…
English

Very encouraging interim data for allogeneic, off-the-shelf CAR-T (healthy donor T cells) cema-cel in 24 patients as first-line consolidation in LBCL.
Licensed by Celgene to Servier, then sublicensed to Allogene.
cellectis.com/en/press/les-d…
English
John De Vos retweetledi

The turning point for rare diseases, which affect >300 million people around the world.
A call to get rid of its many structural obstacles, to consider it as molecular surgery unlike drug treatments
gift link:
nytimes.com/2026/04/09/opi…

English
John De Vos retweetledi

Hey @SciReports is this some sort of joke?? @TimKersjes @SpringerNature please act ASAP. This is an abomination! 👇How the hell did this ever pass peer review, editorial processes???
doi.org/10.1038/s41598…


English






